Home Cart 0 Sign in  
X

[ CAS No. 25194-01-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 25194-01-8
Chemical Structure| 25194-01-8
Chemical Structure| 25194-01-8
Structure of 25194-01-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 25194-01-8 ]

Related Doc. of [ 25194-01-8 ]

Alternatived Products of [ 25194-01-8 ]

Product Details of [ 25194-01-8 ]

CAS No. :25194-01-8 MDL No. :MFCD05670545
Formula : C5H2Cl2N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :BZYQSSVTQJTUDD-UHFFFAOYSA-N
M.W : 192.99 Pubchem ID :3841070
Synonyms :

Calculated chemistry of [ 25194-01-8 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 43.08
TPSA : 58.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.14 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.3
Log Po/w (XLOGP3) : 1.88
Log Po/w (WLOGP) : 2.3
Log Po/w (MLOGP) : 1.3
Log Po/w (SILICOS-IT) : 0.59
Consensus Log Po/w : 1.47

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.56
Solubility : 0.533 mg/ml ; 0.00276 mol/l
Class : Soluble
Log S (Ali) : -2.73
Solubility : 0.355 mg/ml ; 0.00184 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.64
Solubility : 0.441 mg/ml ; 0.00229 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 3.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.87

Safety of [ 25194-01-8 ]

Signal Word:Danger Class:N/A
Precautionary Statements:P280-P301+P312+P330-P302+P352-P305+P351+P338+P310 UN#:N/A
Hazard Statements:H302-H315-H317-H318-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 25194-01-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 25194-01-8 ]
  • Downstream synthetic route of [ 25194-01-8 ]

[ 25194-01-8 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 25194-01-8 ]
  • [ 2587-02-2 ]
YieldReaction ConditionsOperation in experiment
95.1% With hydrogenchloride; iron In ethanol; water at 95℃; for 16 h; (3)
2,6-dichloropyridine-4-amine
To a solution of 2,6-dichloro-4-nitropyridine (14.82 g, 76.79 mmol) in 350 mL ethanol were sequentially added iron powder (19.91 g, 356.58 mmol), water (65.8 mL, 3.6 mol) and concentrated hydrochloric acid (14.1 mL, 464.1 mmol).
After the reaction was performed by stirring for 16 h at 95° C., the reaction solution was cooled to room temperature, adjusted to neutral pH, and subjected to suction filtration.
After the filtrate was concentrated, it was extracted with ethyl acetate.
The organic phase was combined, dried with anhydrous MgSO4, and subjected to rotary evaporation to afford 11.9 g titled product with a yield of 95.1percent.
95.1% With hydrogenchloride; water; iron In ethanol at 95℃; for 16 h; (3)
2,6-dichloropyridine-4-amine
To a solution of 2,6-dichloro-4-nitropyridine (14.82 g, 76.79 mmol) in 350 mL ethanol were sequentially added iron powder (19.91 g, 356.58 mmol), water (65.8 mL, 3.6 mol) and concentrated hydrochloric acid (14.1 mL, 464.1 mmol).
After the reaction was performed by stirring for 16 h at 95 °C, the reaction solution was cooled to room temperature, adjusted to neutral pH, and subjected to suction filtration.
After the filtrate was concentrated, it was extracted with ethyl acetate.
The organic phase was combined, dried with anhydrous MgSO4, and subjected to rotary evaporation to afford 11.9 g titled product with a yield of 95.1percent.
Reference: [1] Patent: US2012/289497, 2012, A1, . Location in patent: Page/Page column 51-52
[2] Patent: EP2524917, 2012, A1, . Location in patent: Page/Page column 58-59
[3] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 3, p. 1511 - 1530
[4] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
[5] ChemCatChem, 2016, vol. 8, # 8, p. 1485 - 1489
[6] ChemCatChem, 2017, vol. 9, # 19, p. 3743 - 3751
  • 2
  • [ 2587-01-1 ]
  • [ 25194-01-8 ]
  • [ 2587-02-2 ]
Reference: [1] Heterocyclic Communications, 2016, vol. 22, # 5, p. 251 - 254
  • 3
  • [ 25194-01-8 ]
  • [ 101079-63-4 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
[2] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
  • 4
  • [ 25194-01-8 ]
  • [ 2897-43-0 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
[2] Patent: US2012/289497, 2012, A1,
[3] Patent: EP2524917, 2012, A1,
[4] Patent: US2012/289497, 2012, A1,
[5] Patent: EP2524917, 2012, A1,
[6] Heterocyclic Communications, 2016, vol. 22, # 5, p. 251 - 254
  • 5
  • [ 25194-01-8 ]
  • [ 2589-12-0 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
[2] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
  • 6
  • [ 1826-67-1 ]
  • [ 25194-01-8 ]
  • [ 67139-79-1 ]
YieldReaction ConditionsOperation in experiment
1.4% at -78℃; for 1 h; Step A: 4,6-dichloro-1 H-pyrrolor3,2-clpyridine: 2,6-dichloro-4-nitro-pyridine (1 1 g, 57 mmol) was dissolved in dry tetrahydrofurane (300 ml_), cooled to -78°C and treated dropwise with bromo(vinyl)magnesium (1 M in THF, 200 ml_, 200 mmol). The reaction was allowed to react at this temperature for 1 hour and then allowed to warm to -20°C. The reaction mixture was then quenched with 200 ml of aqueous NH4CI and the mixture obtained was partitioned in ethyl acetate. The aqueous layer was extracted 3 times with 200 ml of ethyl acetate and the combined organic layer dried over Na2S04, filtered and concentrated in vacuo. Purification by Combi flash chromatography with a column of 120g and a gradient cyclohexane:0-100percent ethyl acetate, and then with a column of 40 g and a gradient dichloromethane:0-10percent ethyl acetate gave the title compound as brown solid (0.150 g, 1 .4percent).
Reference: [1] Patent: WO2013/156431, 2013, A1, . Location in patent: Page/Page column 52
  • 7
  • [ 67-56-1 ]
  • [ 25194-01-8 ]
  • [ 17228-75-0 ]
YieldReaction ConditionsOperation in experiment
88% at 70℃; for 0.416667 h; Microwave irradiation Step 1:
A mixture of 2,6-dichloro-4-nitropyridine (1.0 equiv.), potassium carbonate (3 equiv.) and methanol (20 equiv.) were heated to 70° C. for 25 min in the microwave.
The reaction mixture was diluted with methanol and was decanted from remaining solids.
After concentration, the mixture was partitioned between water and EtOAc.
The organic phase was washed with brine and dried over sodium sulfate.
The solution was concentrated and dried under vacuo to give 2,6-dichloro-4-methoxypyridine in 88percent yield. LCMS (m/z) (M+H)=177.9/179.9, Rt=0.72 min.
Reference: [1] Patent: US2014/275003, 2014, A1, . Location in patent: Paragraph 0700; 0701
[2] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 5, p. 1940 - 1943
  • 8
  • [ 25194-01-8 ]
  • [ 17228-75-0 ]
Reference: [1] Patent: US5624942, 1997, A,
[2] Patent: US5691277, 1997, A,
  • 9
  • [ 25194-01-8 ]
  • [ 60186-13-2 ]
Reference: [1] Patent: US2012/289497, 2012, A1,
[2] Patent: EP2524917, 2012, A1,
[3] Patent: US2012/289497, 2012, A1,
[4] Patent: EP2524917, 2012, A1,
  • 10
  • [ 2587-00-0 ]
  • [ 25194-01-8 ]
YieldReaction ConditionsOperation in experiment
66.4%
Stage #1: With sulfuric acid; nitric acid In water at 148 - 156℃; for 1 h;
Stage #2: With ammonia In water
(2)
2,6-dichloro-4-nitropyridine
To a solution of 95percent concentrated nitric acid (21 mL) and 98percent concentrated sulfuric acid (50 mL) was added 2,6-dichloropyridine-N-oxide (12.8 g, 78 mmol).
After the reaction was performed at 148° C. by stirring for 1 h, it was continued when the temperature was increased to 156° C. until no nitrogen dioxide was released.
The reaction solution was cooled to room temperature, poured into 150 g ice water, and adjusted to pH=6 with ammonia water to precipitate a solid product.
It was subjected to suction filtration.
The resultant crude product was recrystallized with petroleum ether to afford 10 g yellow solid with a yield of 66.4percent.
66.4%
Stage #1: at 148 - 156℃; for 1 h;
Stage #2: With ammonia In water at 20℃;
(2)
2,6-dichloro-4-nitropyridine
To a solution of 95percent concentrated nitric acid (21 mL) and 98percent concentrated sulfuric acid (50 mL) was added 2,6-dichloropyridine-N-oxide (12.8 g, 78 mmol).
After the reaction was performed at 148°C by stirring for 1 h, it was continued when the temperature was increased to 156 °C until no nitrogen dioxide was released.
The reaction solution was cooled to room temperature, poured into 150 g ice water, and adjusted to pH = 6 with ammonia water to precipitate a solid product.
It was subjected to suction filtration.
The resultant crude product was recrystallized with petroleum ether to afford 10 g yellow solid with a yield of 66.4percent.
Reference: [1] Patent: US2012/289497, 2012, A1, . Location in patent: Page/Page column 51-52
[2] Patent: EP2524917, 2012, A1, . Location in patent: Page/Page column 58-59
[3] Organic Letters, 2004, vol. 6, # 5, p. 659 - 662
[4] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
  • 11
  • [ 2587-01-1 ]
  • [ 25194-01-8 ]
Reference: [1] Patent: US4453972, 1984, A,
  • 12
  • [ 14432-16-7 ]
  • [ 25194-01-8 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 3, p. 1511 - 1530
  • 13
  • [ 2402-78-0 ]
  • [ 25194-01-8 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2003, vol. 22, # 12, p. 2133 - 2144
[2] Patent: US2012/289497, 2012, A1,
[3] Patent: EP2524917, 2012, A1,
[4] Patent: US2012/289497, 2012, A1,
[5] Patent: EP2524917, 2012, A1,
[6] Heterocyclic Communications, 2016, vol. 22, # 5, p. 251 - 254
  • 14
  • [ 2587-00-0 ]
  • [ 2587-01-1 ]
  • [ 25194-01-8 ]
Reference: [1] Heterocyclic Communications, 2016, vol. 22, # 5, p. 251 - 254
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 25194-01-8 ]

Chlorides

Chemical Structure| 23056-36-2

[ 23056-36-2 ]

2-Chloro-4-nitropyridine

Similarity: 0.83

Chemical Structure| 2897-43-0

[ 2897-43-0 ]

2,6-Dichloro-3-nitropyridin-4-amine

Similarity: 0.82

Chemical Structure| 2587-02-2

[ 2587-02-2 ]

2,6-Dichloropyridin-4-amine

Similarity: 0.80

Chemical Structure| 16013-85-7

[ 16013-85-7 ]

2,6-Dichloro-3-nitropyridine

Similarity: 0.78

Chemical Structure| 58596-88-6

[ 58596-88-6 ]

2,6-Dichloro-3-methyl-5-nitropyridine

Similarity: 0.76

Nitroes

Chemical Structure| 23056-36-2

[ 23056-36-2 ]

2-Chloro-4-nitropyridine

Similarity: 0.83

Chemical Structure| 2897-43-0

[ 2897-43-0 ]

2,6-Dichloro-3-nitropyridin-4-amine

Similarity: 0.82

Chemical Structure| 16013-85-7

[ 16013-85-7 ]

2,6-Dichloro-3-nitropyridine

Similarity: 0.78

Chemical Structure| 58596-88-6

[ 58596-88-6 ]

2,6-Dichloro-3-methyl-5-nitropyridine

Similarity: 0.76

Chemical Structure| 55304-72-8

[ 55304-72-8 ]

2,3,6-Trichloro-5-nitropyridine

Similarity: 0.75

Related Parent Nucleus of
[ 25194-01-8 ]

Pyridines

Chemical Structure| 23056-36-2

[ 23056-36-2 ]

2-Chloro-4-nitropyridine

Similarity: 0.83

Chemical Structure| 2897-43-0

[ 2897-43-0 ]

2,6-Dichloro-3-nitropyridin-4-amine

Similarity: 0.82

Chemical Structure| 2587-02-2

[ 2587-02-2 ]

2,6-Dichloropyridin-4-amine

Similarity: 0.80

Chemical Structure| 16013-85-7

[ 16013-85-7 ]

2,6-Dichloro-3-nitropyridine

Similarity: 0.78

Chemical Structure| 58596-88-6

[ 58596-88-6 ]

2,6-Dichloro-3-methyl-5-nitropyridine

Similarity: 0.76